News & Updates

Monoclonal antibodies vs COVID-19 up risks of hepatotoxicity, neutropenia
Monoclonal antibodies vs COVID-19 up risks of hepatotoxicity, neutropenia
08 May 2025 byStephen Padilla

Treatment with monoclonal antibodies (mAbs) among COVID-19 patients is associated with a higher risk of hepatotoxicity and neutropenia when compared with standard of care (SoC) or placebo, reports a study.

Monoclonal antibodies vs COVID-19 up risks of hepatotoxicity, neutropenia
08 May 2025
BNT162b2 JN.1-adapted vaccine effective against COVID-19 hospitalization
BNT162b2 JN.1-adapted vaccine effective against COVID-19 hospitalization
06 May 2025 byKanas Chan

BNT162b2 JN.1-adapted vaccine provides protection against COVID-19–related hospitalization in Europe, a case-control study using the id.DRIVE platform has shown.

BNT162b2 JN.1-adapted vaccine effective against COVID-19 hospitalization
06 May 2025
MSC therapy delivers long-term benefit in severe COVID-19
MSC therapy delivers long-term benefit in severe COVID-19
02 May 2025 byAudrey Abella

A recent study suggests patients with severe COVID-19 may benefit from human mesenchymal stem cell (MSC) therapy.

MSC therapy delivers long-term benefit in severe COVID-19
02 May 2025